Cresilon
NY - BrooklynBiotechnology
Focus: Cresilon is a Brooklyn-based biotechnology company specializing in hemostatic gel technology for ophthalmology and neurology applications. The company operates as a focused biotech with a lean footprint and targeted therapeutic focus.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
9
Should You Work at Cresilon?
AI assessmentCresilon represents a high-risk, high-impact pre-revenue opportunity best suited for mission-driven scientists willing to tolerate significant uncertainty for foundational impact.
Why Work Here
- Early-stage biotech with focus on novel hemostatic gel platform—opportunity to shape product development from foundational stage
- Dual therapeutic areas (ophthalmology and neurology) provide technical breadth across distinct clinical specialties
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cresilon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.